212 related articles for article (PubMed ID: 35440807)
41. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway.
Li X; Wang S; Mu W; Barry J; Han A; Carpenter RL; Jiang BH; Peiper SC; Mahoney MG; Aplin AE; Ren H; He J
J Exp Clin Cancer Res; 2022 Jan; 41(1):41. PubMed ID: 35086548
[TBL] [Abstract][Full Text] [Related]
42. MIAT shuttled by tumor-secreted exosomes promotes paclitaxel resistance in esophageal cancer cells by activating the TAF1/SREBF1 axis.
Zhang S; Zhong J; Guo D; Zhang S; Huang G; Chen Y; Xu C; Chen W; Zhang Q; Zhao C; Liu S; Luo Z; Lin C
J Biochem Mol Toxicol; 2023 Aug; 37(8):e23380. PubMed ID: 37132394
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
[TBL] [Abstract][Full Text] [Related]
44. Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway.
Fan JT; Zhou ZY; Luo YL; Luo Q; Chen SB; Zhao JC; Chen QR
Neoplasia; 2021 Jul; 23(7):692-703. PubMed ID: 34153644
[TBL] [Abstract][Full Text] [Related]
45. Hsa_circ_0007142 contributes to cisplatin resistance in esophageal squamous cell carcinoma via miR-494-3p/LASP1 axis.
Chang N; Ge N; Zhao Y; Yang L; Qin W; Cui Y
J Clin Lab Anal; 2022 May; 36(5):e24304. PubMed ID: 35312115
[TBL] [Abstract][Full Text] [Related]
46. Exosomal lncRNA HOTAIR Promotes the Progression and Angiogenesis of Endometriosis via the miR-761/HDAC1 Axis and Activation of STAT3-Mediated Inflammation.
Zhang L; Yu Z; Qu Q; Li X; Lu X; Zhang H
Int J Nanomedicine; 2022; 17():1155-1170. PubMed ID: 35321026
[TBL] [Abstract][Full Text] [Related]
47. Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells.
Li D; Sun FF; Wang D; Wang T; Peng JJ; Feng JQ; Li H; Wang C; Zhou DJ; Luo H; Fu ZQ; Zhang T
Oncol Res; 2020 Dec; 28(5):467-481. PubMed ID: 32560747
[TBL] [Abstract][Full Text] [Related]
48. miR-34a attenuates glioma cells progression and chemoresistance via targeting PD-L1.
Wang Y; Wang L
Biotechnol Lett; 2017 Oct; 39(10):1485-1492. PubMed ID: 28721584
[TBL] [Abstract][Full Text] [Related]
49. MiR-296-5p inhibits cell invasion and migration of esophageal squamous cell carcinoma by downregulating STAT3 signaling.
Wang ZZ; Luo YR; Du J; Yu Y; Yang XZ; Cui YJ; Jin XF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5206-5214. PubMed ID: 31298412
[TBL] [Abstract][Full Text] [Related]
50. Exosomal lncRNA LINC01711 facilitates metastasis of esophageal squamous cell carcinoma via the miR-326/FSCN1 axis.
Xu ML; Liu TC; Dong FX; Meng LX; Ling AX; Liu S
Aging (Albany NY); 2021 Aug; 13(15):19776-19788. PubMed ID: 34370713
[TBL] [Abstract][Full Text] [Related]
51. Orexin A Suppresses the Expression of Exosomal PD-L1 in Colon Cancer and Promotes T Cell Activity by Inhibiting JAK2/STAT3 Signaling Pathway.
Wen J; Chang X; Bai B; Gao Q; Zhao Y
Dig Dis Sci; 2022 Jun; 67(6):2173-2181. PubMed ID: 34097168
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
[TBL] [Abstract][Full Text] [Related]
53. [The IL-6/STAT3 signaling pathway mediated by radiotherapy regulates the expression of PD-L1 in esophageal cancer cells].
Zhou YC; Pang XZ; Zhu HL; He Y; Shen Y; Ma DY
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):389-394. PubMed ID: 35615794
[No Abstract] [Full Text] [Related]
54. MiR-126 promotes esophageal squamous cell carcinoma via inhibition of apoptosis and autophagy.
Li M; Meng X; Li M
Aging (Albany NY); 2020 Jun; 12(12):12107-12118. PubMed ID: 32554852
[TBL] [Abstract][Full Text] [Related]
55. MiR-34a-5p/PD-L1 axis regulates cisplatin chemoresistance of ovarian cancer cells.
Zuo Y; Zheng W; Liu J; Tang Q; Wang SS; Yang XS
Neoplasma; 2020 Jan; 67(1):93-101. PubMed ID: 31777260
[TBL] [Abstract][Full Text] [Related]
56. Restoration of circPSMC3 sensitizes gefitinib-resistant esophageal squamous cell carcinoma cells to gefitinib by regulating miR-10a-5p/PTEN axis.
Zhu H; Du F; Cao C
Cell Biol Int; 2021 Jan; 45(1):107-116. PubMed ID: 32997362
[TBL] [Abstract][Full Text] [Related]
57. miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2.
Lin WC; Chen LH; Hsieh YC; Yang PW; Lai LC; Chuang EY; Lee JM; Tsai MH
Carcinogenesis; 2019 Jul; 40(7):883-892. PubMed ID: 30576425
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN.
Zhang N; Liu JF
Bioengineered; 2020 Dec; 11(1):972-983. PubMed ID: 32970954
[TBL] [Abstract][Full Text] [Related]
59. RNA sequencing of exosomes revealed differentially expressed long noncoding RNAs in early-stage esophageal squamous cell carcinoma and benign esophagitis.
Tian L; Yang L; Zheng W; Hu Y; Ding P; Wang Z; Zheng D; Fu L; Chen B; Xiao T; Wang Y; Chen F; Liu J; Gao K; Shen S; Zhai R
Epigenomics; 2020 Mar; 12(6):525-541. PubMed ID: 32043367
[No Abstract] [Full Text] [Related]
60. Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis.
Liu H; Zhang J; Luo X; Zeng M; Xu L; Zhang Q; Liu H; Guo J; Xu L
Oncol Res; 2020 Feb; 28(1):65-73. PubMed ID: 31558183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
